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Abstract
Endometriosis affects approximately 15% of reproductive aged
women and is associated with chronic pelvic pain and infertility.
However, the molecular mechanisms by which endometriosis
impacts fertility are poorly understood. The developmentally regu-
lated, imprinted H19 long noncoding RNA (lncRNA) functions to
reduce the bioavailability of microRNA let-7 by acting as a molecu-
lar sponge. Here we report that H19 expression is significantly
decreased in the eutopic endometrium of women with endometri-
osis as compared to normal controls. We show that decreased H19
increases let-7 activity, which in turn inhibits Igf1r expression at
the post-transcriptional level, thereby contributing to reduced
proliferation of endometrial stromal cells. We propose that pertur-
bation of this newly identified H19/Let-7/IGF1R regulatory path-
way may contribute to impaired endometrial preparation and
receptivity for pregnancy in women with endometriosis. Our find-
ing represents the first example of a lncRNA-based mechanism in
endometriosis and its associated infertility, thus holding potential
in the development of novel therapeutics for women with endo-
metriosis and infertility.
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Introduction
Endometriosis is defined as the presence of endometrial glands and
stroma outside of the uterus (reviewed in Macer & Taylor, 2012).
Approximately 6–15% of reproductive aged women are affected by
endometriosis although the true incidence is unknown because
some patients remain asymptomatic. The classic symptoms include
dysmenorrhea, chronic pelvic pain, dyspareunia, irregular uterine
bleeding, and infertility. In some cases, the disease can be debilitat-
ing and exert a dramatic impact on health and quality of life
(reviewed in Macer & Taylor, 2012). There is a clear association
between endometriosis and infertility. Some studies suggest that
25–50% of women with infertility also have endometriosis and
30–50% of women with endometriosis are infertile (Meuleman et al,
2009). However, despite the well-established link between endo-
metriosis and infertility, the mechanism by which endometriosis
impacts fertility is poorly understood.
The insulin-like growth factors, including insulin, IGF1, and
IGF2, play important roles in mediating and modulating sex
hormone-induced growth and differentiation of endometrial cells
(Tang et al, 1994; Baker et al, 1996; Adriaenssens et al, 1999;
Ivanga et al, 2007). Insulin exerts its function through interaction
with the insulin receptor (INSR), whereas actions of both IGF1 and
IGF2 are mainly mediated by the IGF1 receptor (IGF1R) (LeRoith
et al, 1995). Of particular interest is the fact that IGF1-deficient
female mice are infertile and exhibit uterine hypoplasia, suggesting
that IGF1 is important for uterine growth and function (Baker et al,
1996). Igf1 and Igf1r are expressed in both the epithelium and
stroma of the endometrium. Their expression levels fluctuate during
the menstrual cycle with the highest levels of expression being in
the late proliferative phase. Their expression is regulated, at least in
part by ovarian steroids, mainly 17-beta estradiol (E2) (Tang et al,
1994; Baker et al, 1996). Activation of the PI3K/AKT and Ras/Raf/
MAPK signal transduction pathways through the IGF1 action
promotes uterine cell growth and proliferation (Tang et al, 1994;
LeRoith et al, 1995; Ivanga et al, 2007). Consistently, Igf1r over-
expression with heightened AKT activity has been detected in hyper-
plastic endometrium (McCampbell et al, 2006). However, it is not
known whether the expressions of Igf1r and/or Igf1 are altered in
the eutopic endometrium of women with endometriosis and if so,
what the underlying mechanism might be.
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The H19 long noncoding RNA (lncRNA) is expressed from the
imprinted gene locus that also contains the reciprocally imprinted
Igf2 gene (reviewed in Gabory et al, 2010). The H19 gene encodes a
2,600-nt capped, spliced, and polyadenylated noncoding RNA that is
predominantly cytoplasmic (Gabory et al, 2010; Monnier et al,
2014). In human and mouse endometrium, H19 is expressed in a
menstrual cycle-dependent fashion, with increased expression
during the late proliferative phase, but the physiological significance
of this expression is unclear (Ariel et al, 1997; Adriaenssens et al,
1999; Tanos et al, 2004; Korucuoglu et al, 2010). Endometrial H19
expression is positively regulated by E2 and negatively regulated by
progesterone in the mouse (Ivanga et al, 2007). Unlike Igf1 and
Igf1r, which are expressed in both the epithelial and stromal
compartments (Tang et al, 1994), H19 expression is confined to the
endometrial stroma (Ariel et al, 1997; Tanos et al, 2004). It has
been recently shown that women with unexplained infertility show
decreased H19 expression in the eutopic endometrium suggesting a
direct clinical link (Korucuoglu et al, 2010).
We have recently found that the H19 lncRNA (called H19 herein)
reduces the bioavailability of the microRNA let-7 by acting as a
molecular sponge (Kallen et al, 2013). Let-7 inhibits target gene
expression by binding to complementary sequences in the mRNA,
which leads to translational repression and mRNA degradation
(Roush & Slack, 2008; Fabian & Sonenberg, 2012). A limited number
of genes have been identified as let-7 targets and among them is
Igf1r (Zhu et al, 2011). Given that women with unexplained infertil-
ity show decreased H19 expression in their eutopic endometrium
(Korucuoglu et al, 2010) and that H19 regulates let-7 (Kallen et al,
2013) which targets Igf1r (Zhu et al, 2011), we wished to determine
the physiological role of H19 in the endometrium and its relationship
with the IGF signaling in endometriosis.
In this report, we show that the expression of both H19 and Igf1r
is significantly decreased in the eutopic endometrium of women
with endometriosis. We provide evidence that decreased H19
expression leads to increased bioavailability of let-7, which in turn
inhibits Igf1r expression at the post-transcriptional level, thereby
contributing to reduced stromal cell proliferation. Perturbation of
this newly identified H19/Let-7/IGF1R regulatory pathway may
contribute to impaired endometrial preparation and receptivity in
women with endometriosis.
Results
The expression of H19 and Igf1r is decreased in the endometrium
of women with endometriosis
To determine whether the expressions of H19, Igf1r, Igf1, Igf2, and
Insr might be altered in the endometrium of woman with endometri-
osis, eutopic endometrial biopsies were collected during the late
proliferative phase from women with and without endometriosis
(see Appendix Table S1 for characterization of the patients). The
RNA levels were assessed by reverse-transcription and quantitative
real-time PCR (RT–qPCR). Mann–Whitney’s U-test revealed a signif-
icant H19 decrease in the endometriosis (Endo) compared to the
nonendometriosis (Ctl) group (medians of Endo and Ctl were 1.96
and 8.10, respectively; P = 0.035, Fig 1A). Intriguingly, there was a
concomitant decrease in Igf1r in the Endo compared to the Ctl group
(medians of Endo and Ctl were 0.46 and 1.11, respectively;
P = 0.001, Fig 1B). Spearman correlation suggested a positive rela-
tionship between H19 and Igf1r (Fig 1C, P = 0.014), implicating
possible in vivo interactions between the two genes. On the
contrary, there was no significant difference in the levels of Igf1,
Igf2, and Insr between the two groups (Fig 1D–F). Together, these
results suggested that decreased expression of H19 and Igf1r might
contribute to impaired development and function of eutopic endo-
metrium in patients with endometriosis.
The H19/Let-7 axis regulates Igf1r expression in endometrial
stromal cells
To begin to elucidate the molecular pathway by which H19/Igf1r
might regulate endometrial cell function, we used primary endome-
trial stromal cells derived from human endometrial biopsies as a
model, as these cells express both H19 and Igf1r in vivo (Tang et al,
1994; Ariel et al, 1997; Tanos et al, 2004). We previously demon-
strated that in skeletal muscle and tumor cells H19 functions to
reduce the bioavailability of let-7 by acting as a molecular sponge
(Gao et al, 2014; Yan et al, 2014). H19 contains multiple let-7-bind-
ing sites that sequester let-7 and prevent it from binding to its target
mRNA (Kallen et al, 2013). Thus, it is the bioavailability of let-7,
hence the relative expression levels between H19 and let-7 and not
its absolute expression level, that determines target gene expression.
Both human and mouse Igf1r mRNA contain let-7-binding sites at its
30 UTR, and Igf1r is a validated target of let-7 (Zhu et al, 2011).
Given the concomitant downregulation of H19 and Igf1r in the
eutopic endometrium of endometriosis (Fig 1A and B), we sought to
determine whether H19, through sequestering let-7, might regulate
Igf1r expression in the human endometrial stromal cells. Thus, H19
knockdown and overexpression experiments were performed in
endometrial stromal cells derived from four patients with endo-
metriosis. We performed knockdown experiments in two patient
cells (#166 and #80) that expressed high levels of endogenous H19,
and overexpression experiments in other two patient cells (#98 and
#212S) with relatively low endogenous H19 (Appendix Fig S1). The
rationale for selecting low H19 cells for overexpression was to avoid
possible overexpression-induced artifact. Combined results from
two patient cells in each group are presented in Figs 2 and 3, with
results of each individual cells shown in Appendix Figs S2 and S3.
For H19 knockdown experiments, a siRNA specific for human
H19 (siH19, Kallen et al, 2013; Yan et al, 2014) was used in the
presence and absence of let-7-specific inhibitor (iLet7, Kallen et al,
2013; Yan et al, 2014), followed by the analysis of Igf1r expression
at 48 h post-transfection. iLet7s are chemically modified, single-
stranded nucleic acids that specifically bind to let-7 and block its
function. The purpose for using iLet7 was to confirm the contribu-
tion of let-7 to the H19-mediated pathway, as H19 has other
functions in addition to sequestering let-7 (Keniry et al, 2012;
Venkatraman et al, 2013; Dey et al, 2014; Monnier et al, 2014). The
effect of H19 knockdown (i.e., downregulation of Igf1r) would be
abrogated in the presence of iLet7, which acts to neutralize let-7
released from H19 sequestration. When H19 was downregulated by
siH19 in the absence of iLet7 (Fig 2A, compare the middle column
to the left column), there was a decrease in the level of Igf1r mRNA
(Fig 2B, compare the middle column to the left column). This
suggested that H19 deficiency led to enhanced let-7 action, enabling
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it to repress the expression of Igf1r, a known target of let-7 (Zhu
et al, 2011). The level of Igf1r mRNA was restored to that of control
(Fig 2B, compare the right column to the left column) when H19
was knocked down in the presence of iLet7 (Fig 2A, compare the
right column to the left column). Changes in the Igf1r protein level
in response to H19 knockdown with or without iLet7 closely
mimicked those of the Igf1r mRNA (Fig 2C and D). Results from the
individual patient cells are shown in Appendix Fig S2A–H. Together,
these results suggested that in endometrial stromal cells H19 regu-
lates Igf1r expression post-transcriptionally by affecting the bioavail-
ability of let-7. As the expression of Igf1r could be fully rescued
through blocking let-7 by iLet7 in the context of H19 knockdown at
both mRNA and protein levels (Fig 2A–D), the contribution of let-7
in the H19-mediated pathway in endometrial stromal cells is
strongly supported.
To provide further evidence in support of this notion, H19 over-
expression experiments were carried out. Thus, the cells were trans-
fected with a human H19-expressing vector pH19 (Kallen et al,
2013; Yan et al, 2014) or empty vector, and effects on Igf1r expres-
sion were analyzed 48 h later. When H19 was overexpressed
(Fig 2E, compare right column with the left column), an increase in
the Igf1r mRNA level was observed (Fig 2F, compare right column
with the left column). There was an increase in the Igf1r protein
level as well (Fig 2G and H, compare the right columns with the left
column). The lower Igf1r protein level in Fig 2G, lane 1, compared
to that in Fig 2C, lane 1, was consistent with the relatively lower
H19 levels in the corresponding cells (Appendix Fig S1). Results
from the individual patient cells are shown in Appendix Fig S2I–P.
These results were consistent with the view that an elevated level of
H19 led to reduced bioavailability of let-7, which in turn relieved
the inhibition of Igf1r expression by let-7. Combining with the
siRNA knockdown results (Fig 2A–D), we concluded that H19 regu-
lates Igf1r expression at the post-transcriptional level in human
endometrial stromal cells and that this regulation is at least in part
mediated by let-7.
H19 promotes proliferation of endometrial stromal cells
It is well established that IGF1 acts on its receptor IGF1R to activate
the PI3K/AKT and Ras/Raf/MAPK signal transduction pathways,
thereby promoting uterine cell proliferation (Tang et al, 1994;
LeRoith et al, 1995; Ivanga et al, 2007). Indeed, Igf1r overexpression
with heightened AKT activity has been detected in hyperplastic
endometrium (McCampbell et al, 2006). Our results have demon-
strated that in endometrial stromal cells H19 promotes Igf1r expres-
sion via reducing the bioavailability of let-7 (Fig 2; Appendix Fig
S2). Based on these findings, we predicted that H19 knockdown or
overexpression would negatively or positively affect the prolifera-
tion of endometrial stromal cells. Results shown in Fig 3; Appendix
Fig S3 are consistent with our prediction.
When H19 was knocked down by siH19 (Fig 3A, first column on
the left, compare blue bar to green bar), the level of Igf1r mRNA
was decreased as expected (second column). Under these condi-
tions, a significant decrease in the number of viable cells was also
A B C
D E F
Figure 1. The expressions of H19 and Igf1r are significantly decreased in the eutopic endometrium of women with endometriosis compared to those without
endometriosis.
A–F (A, B, D–F) RNA levels determined by RT–qPCR. Results are presented as mean  SD, n = 10. P-values are indicated on the top of each plot. (C) Spearman
correlation suggests an in vivo positive correlation between the expressions of H19 and Igf1r in a statistically significant manner. Spearman correlation coefficient,
P-values, and sample numbers are marked on the top left of the plot.
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observed (Fig 3B) even with decreased cell death (Fig 3C). This
suggested that downregulation of H19 caused decreased prolifera-
tion of endometrial stromal cells, which was further confirmed by
decreased expression of cell proliferation markers Ki67 (Scholzen &
Gerdes, 2000) and PCNA (Moldovan et al, 2007) (Fig 3A, right two
columns, compare green bars to pink bars). Consistent with the
knockdown results, overexpression of H19 (Fig 3D, left column) led
to an increase in the expression of Igf1r, Ki67, and PCNA (second
through fourth columns), with a concomitant increase in the
number of viable cells (Fig 3E) even in the presence of more apopto-
tic activity (Fig 3F). As H19 knockdown simultaneously reduced cell
proliferation and cell death (Fig 3B and C) and its overexpression
elicited opposite effects (Fig 3E and F), a dual role of H19 in regulat-
ing endometrial stromal cell growth and survival could be proposed,
although the mechanism underlying the putative H19-mediated
crosstalk remains to be investigated. Results from the individual
patient cells are shown in Appendix Fig S3.
Estrogen stimulates H19 expression in endometrial stromal cells
In the mouse uterus, H19 expression is stimulated by 17-beta estra-
diol (E2) and follows a cyclic pattern (Adriaenssens et al, 1999).
The expression is lowest during the proestrus and gradually
increases during the proliferative phase until ovulation. It remains
high during the early secretory phase and sharply declines during
the late secretory phase. A similar cyclic pattern of H19 expression
was observed in the human endometrium (Ariel et al, 1997). Inter-
estingly, the expression pattern of Igf1r in the human endometrium
mimics that of H19 (Ivanga et al, 2007). Given that E2 acts as a
potent stimulator of IGF1 signaling in the endometrium (Ivanga
et al, 2007) and that H19 stimulates Igf1r expression (Fig 2; Appen-
dix Fig S2), we hypothesized that E2 may stimulate H19 expression
which in turn upregulates Igf1r expression, thereby promoting IGF1
signaling in the human endometrial cells. To test this hypothesis,
human endometrial stromal cells were treated with E2 and H19
expression was analyzed after 48 h of treatment. Results showed
that E2 stimulated H19 expression by approximately 2-fold (Fig 3G)
irrespective of endogenous H19 levels (Appendix Fig S2), which
was consistent with our hypothesis.
Discussion
This study investigates the long noncoding RNA H19, its interaction
with the IGF signaling pathway via the microRNA let-7, and the role
they play in the human endometrium. Women with endometriosis
have altered gene expression in the eutopic endometrium that may
impair fertility. Our results show that women with endometriosis
A B C D
E F G H
Figure 2. H19 promotes Igf1r expression in endometrial stromal cells by inhibiting let-7.
A–D Endometrial stromal cells from patients #166 and #80 were each transfected with a mixture of siCon (control siRNA) and microRNA inhibitor control (iCon), siH19
and iCon, or siH19 and iLet7 (let-7-specific inhibitor). RNA and proteins were analyzed at 48 h post-transfection. Combined results from the two patient cells are
presented. Western blot gels from #166 cells are shown in (C). Quantitation of Western blots combining both patient cells are shown in (D).
E–H Endometrial stromal cells from patients #98 and #212S were each transfected with empty vector or pH19. RNA and proteins were analyzed 48 h post-transfection.
Combined results from the two patient cells are presented. Western blot gels from #98 cells are shown in (G). Quantitation of Western blots combining both
patient cells are shown in (H).
Data information: Results are presented as mean  SD, n = 6. P-values are indicated on the top of each plot.
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have decreased H19 expression as well as a concomitant decrease in
the level of Igf1r mRNA in the eutopic endometrium compared to
women without endometriosis. Using primary cultured human
endometrial stromal cells as a model, we provide evidence that H19
regulates Igf1r expression in endometrial stromal cells by sequester-
ing let-7 and reducing its bioavailability. We show that H19
promotes proliferation of endometrial stromal cells and, further-
more, estradiol stimulates H19 expression, which upregulates Igf1r
and promotes IGF1 signaling. The combination of results from our
in vivo and in vitro studies strongly suggests a regulation of Igf1r by
H19 and its physiological relevance in the human endometrium.
However, it is almost certain that additional regulatory circuits
are involved in the H19/Igf1r pathway given that H19 is a multi-
functional RNA and that Igf1r can be regulated by mechanisms other
than H19.
We did not observe a statistically significant difference in H19
expression in the cultured endometrial stromal cells from women
with and without endometriosis (data not shown). This was incon-
sistent with our in vivo data demonstrating significantly lower H19
expression in women with endometriosis as compared to woman
without endometriosis (Fig 1A). This apparent discrepancy is likely
the result of in vitro manipulation of isolated stromal cells. The
stress of in vitro culture combined with the loss of in vivo crosstalk
with other cell types may have contributed to the altered H19
expression in vitro, making it less reflective of the in vivo condition.
In support of this notion, in vitro culture of human placental mesen-
chymal stem cells has been reported to induce epigenetic alterations
(Zhu et al, 2015). Despite the above-mentioned caveat, the
combined results from four different patient cells, with both H19
knockdown and overexpression, strongly point to the notion that
the H19/Let-7/IGF1R pathway is likely operating in controlling
endometrial stromal cell proliferation. Thus, primary endometrial
stromal cells remain a valuable in vitro model for the mechanistic
dissection of the molecular interplay between H19 and its regulated
genes, with the potential of identifying novel therapeutic targets for
future intervention.
Endometriosis has been traditionally viewed as a proliferative
disorder with growth of endometrial cells in ectopic locations;
however, previous data have shown proliferation defects in the
eutopic endometrium of women with endometriosis compared to
women without endometriosis. Women with endometriosis develop
significantly lower peak endometrial thickness when compared to
women without endometriosis (Bromer et al, 2009). Normal eutopic
endometrium grows quickly during the proliferative phase of the
menstrual cycle, but our findings suggest that alterations of the
H19/Let-7/IGF1R pathway may impair eutopic endometrial cell
growth in women with endometriosis.
It has been proposed that endometriosis causes adhesions and
scarring of the pelvic anatomy, which can impair oocyte release or
cause tubal blockage (Schenken et al, 1984). Additionally, patients
may have altered peritoneal function with an increase in inflamma-
tory cytokines due to peritoneal disease or involvement. Two large
randomized controlled trials which compared the fecundity of surgi-
cal treated and untreated women with endometriosis concluded that
women with surgically treated mild endometriosis continue to have
impaired fecundity, suggesting that visible endometriotic lesions do
not represent the sole mechanism of the fertility impairment
(Marcoux et al, 1997; Parazzini, 1999). Indeed, a number of studies
have suggested that endometriosis causes dysfunction of the
eutopic endometrium. Women with endometriosis display aberrant
A
D E F
B C
G
H
Figure 3. H19 stimulates proliferation of endometrial stromal cells.
A–F The indicated cells were transfected with siCon, siH19, empty vector, or pH19. RNA, cell viability (as indicated by viable cell numbers), and caspase activity (as a
readout for apoptosis) were analyzed 48 h post-transfection. Combined results from two patient cells in each group are presented.
G E2 stimulates H19 expression in endometrial stromal cells. Endometrial stromal cells #166 and #98 were stimulated with E2 (+) or vehicle () for 48 h, followed by
RT–qPCR analysis of RNA extracted from the cells. Results combining two patient cells are shown.
H A proposed model of the H19/Let-7/IGF1R-mediated regulation of endometrial stromal cell proliferation. During the proliferative phase of the endometrium, E2
stimulates the expression of H19. As its level rises, H19 acts as a sponge to sequester let-7 and prevent it from inhibiting its target gene Igf1r. Increased IGF1R
protein level leads to increased IGF1 signaling with a biological endpoint of increased proliferation of endometrial stromal cells.
Data information: Results are presented as mean  SD, n = 6. P-values are indicated on the top of each plot.
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expression of genes in their eutopic endometrium, many of which
(including HOXA10, aromatase, progesterone receptors, matrix
metalloproteinases, and ab-integrin) have been implicated in endo-
metrial development and receptivity (reviewed in Macer & Taylor,
2012; Hurst et al, 2014). Our results unveil new gene regulatory
pathways that may underlie the dysfunctional endometrial develop-
ment seen in women with endometriosis.
In light of our findings described in this manuscript, we propose
the following model of the H19/Let-7/IGF1R-mediated regulation of
endometrial cell proliferation (Fig 3H). During the proliferative
phase of the menstrual cycle, estradiol stimulates the expression of
H19 in the endometrium. As levels of H19 rise, it acts as a sponge to
sequester let-7, thereby preventing let-7 from inhibiting its target
gene Igf1r. Increased Igf1r protein levels lead to increased IGF1
signaling with a biological endpoint of increased proliferation of
endometrial stromal cells. This pathway appears to be altered in
women with endometriosis. Endometriosis patients have decreased
H19 expression at the level of eutopic endometrium, which leads to
increased let-7 bioavailability. This allows for the increased inhibi-
tion of Igf1r and thus decreased IGF1 signaling, which ultimately
leads to decreased stromal cell proliferation. Alterations in this H19/
Let-7/IGF1R-mediated regulation of endometrial cell proliferation
may represent a potential mechanism for infertility in women with
endometriosis. Further research is needed to improve our under-
standing of this pathway and to identify novel molecular targets for
intervention and treatment of infertility in this patient population.
Materials and Methods
Materials
Antibodies for IGF1R (Cell Signaling, 3027; used at a dilution of
1:1,000) and b-tubulin (TUBB) (Abcam, ab6046; used at a dilution
of 1:3,000) were purchased. Human H19-specific siRNA (siH19),
nontargeting siRNA (siCon), let-7 inhibitor (iLet7), anti-miR control
(iCon), plasmids expressing human H19 (pH19), and empty vector
were previously described (Kallen et al, 2013; Yan et al, 2014).
17b-estradiol (E2) was purchased from Sigma-Aldrich (E8875-1G).
Tissue sample collection
Women undergoing laparoscopic surgery for suspected endometri-
osis or idiopathic infertility at Bern Hospital in Switzerland were
identified. Informed consent was obtained for each patient prior to
surgery. Surgery was scheduled to occur during the late proliferative
phase of the menstrual cycle, and endometrial tissue samples were
collected at the time of surgery. For all the patients in the study,
samples of eutopic endometrium were collected using a soft curette
(Pipelle-de-Cornier, Laboratoire CCD, France). For patients with
confirmed endometriosis, a sample of ectopic endometrium was also
collected. After the samples were collected, the tissue was stored in
RNAlater at 80°C. Endometriotic lesions were confirmed by histo-
logical examination. Patient data were also collected including the
use of hormonal medication in the 3 months prior to surgery, age,
and body mass index (BMI). The tissue collected for this study
included eutopic endometrial biopsies from 10 women with endo-
metriosis and 10 women without endometriosis.
Analysis of gene expression in eutopic endometrial tissue
For eutopic endometrial biopsies, approximately 30 mg of tissue
was excised and homogenized in a FastPrep 120 tissue homogenizer
(30 s at 4.0 m/s) in cell lysis buffer (Qiagen, Hombrechtikon,
Switzerland). The remaining RNA isolation was performed with the
RNAeasy mini kit (Qiagen) and TurboDNase (Ambion, Life Technol-
ogies, Zug, Switzerland) for genomic DNase digestion. One micro-
gram of total RNA was reverse-transcribed in a 25-ll reaction with
the Moloney murine leukemia virus (MMLV) reverse transcriptase
(Promega, Du¨bendorf, Switzerland) and random primers. The
resulting cDNA was diluted 1:20, and the absence of genomic DNA
was confirmed with a reverse-transcriptase negative control.
The quantitative real-time polymerase chain reaction (qPCR) was
performed with the Rotor-Gene FAST SYBR green PCR kit (Qiagen)
in a Rotor-Gene RG 2000 (Corbett Research, NSW, Australia) under
the following conditions: 95°C for 5 min, followed by 40 cycles of
95°C for 5 s and 60°C for 10 s. Primers were synthesized by Micro-
synth, Balgach, Switzerland, and the sequences are defined in
Appendix Table S2. Specificity of amplification was confirmed by
melting curve analysis and the absence of amplification in the
no-template control.
Statistical analysis of data from human tissue samples
The most appropriate reference genes for the tissue included in this
study were determined from a panel of 8 reference genes and using
the geNORM program as part of the qBASE+ software suite (Bioga-
zelle, Zwijnaarde, Belgium) (Vandesompele et al, 2002). Reaction
efficiency of each gene was also included in the analysis and was
calculated via linear regression (Ruijter et al, 2009). Analysis of the
reference gene panel indicated that a panel of at least seven refer-
ence genes was required to reach an adequately low variability
(< 0.15) among the samples in the study.
Gene expression was determined based on the DDCt method and
calculated by the qBASE+ software. Results are expressed as fold
change from a standard reference sample included in each run. The
analyses of gene expression were calculated via a nonparametric
Mann–Whitney U-test. P-values of 0.05 or less were considered
significant.
Human endometrial stromal cell isolation and culture
Endometrial tissues were obtained from healthy reproductive aged
women undergoing elective gynecological surgery or women diag-
nosed with endometriosis. Tissue collection and usage were
approved by the Yale Human Investigations Committee. Endome-
trial stromal cells were isolated using the methods previously
reported (Yang et al, 2012). Cells were maintained in DEME/F12
(1:1) (Gibco, Life Technologies, 11330-032), supplemented with
10% FBS, 1 mM L-glutamine, and 1% penicillin–streptomycin in
5% CO2 atmosphere at 37°C.
RT–qPCR and Western blot analyses
RT–qPCR and Western blot analysis were carried out as previously
described Kallen et al (2013). The PCR primers for the indicated
human genes are listed in Appendix Table S2.
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H19 siRNA knockdown and let-7 inhibitor rescue and H19
overexpression experiments
Cells were transfected in a 24-well plate scale. To prepare siRNA
transfection solution for each well, 30 pmol of siCon or siH19 was
mixed with 100 ll OPTI-MEM by gentle pipetting. In parallel, 3 ll
Lipofectamine 2000 was mixed with 100 ll OPTI-MEM. Following
5 min of incubation at room temperature (RT), the two were mixed
by gentle pipetting and incubated for 20 to 30 min at RT to allow
siRNA/lipid complexes to form. At the end of incubation, the 200 ll
transfection solution was used to re-suspend the cell pellet
(~1.5 × 105 cells/well). After incubation at RT for 10 min, regular
growth medium was added at a ratio of 1:5 (1 volume of transfec-
tion solution/4 volumes of growth medium) and the cell suspension
was transferred to the culture plate. After 24-h incubation at 37°C in
5% CO2, the medium was replaced with fresh growth medium.
RNAs and proteins were extracted and analyzed at the indicated
time points following transfection.
Plasmid DNA transfections were carried out as described for
siRNA, except that 1 lg DNA in 25 ll OPTI-MEM and 1 ll Lipofec-
tamine 2000 in 25 ll OPTI-MEM were used for each well of cells
(the 50 ll of final transfection reagent with 500 ll of regular growth
medium was added to each well). For iLet7 rescue experiments,
30 pmol of siCon/siH19 and 60 pmol of iCon/iLet7 were used for
each well of cells.
Cell viability and apoptosis
These were performed as previously described Yan et al (2015).
Briefly, cells were transfected and seeded in 96-well plates at a
density of 5 × 103/well. Cell viability and caspase 3/7 activity were
measured 48 h post-transfection using the CellTiter-Blue Cell
Viability kit (Promega) and the Apo-ONE Homogeneous Caspase-3/
7 Assay kit (Promega), respectively, according to the manufacturer’s
protocols.
E2 treatment of human endometrial stromal cells
Cells were seeded in 24-well plates in regular complete growth
media at a density of ~1.5 × 105 per well. The next day, media were
replaced with serum-free media containing E2 (final concentration
of 108 M), followed by incubation for the indicated time duration.
E2 was replenished every 24 h in fresh serum-free media until RNA
extraction for further analyses.
Statistical analysis of data from human stromal cell experiments
All data are presented as mean  standard deviation (SD) unless
otherwise indicated. Data were analyzed using two-tailed Student’s
t-test for the average differences. Statistical analyses were
performed using the Statistical Package for the Social Science
(SPSS) computer software version 17.0 (IBM SPSS Statistics,
Chicago, IL, USA). Figures were constructed using Prism 6 version
6.0f (GraphPad Software, Inc.). P-values of 0.05 or less were
considered significant.
Expanded View for this article is available online:
http://embomolmed.embopress.org
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